RE: Takeover3 May 2018 09:00
@Andie,
It's amazing how everyone says they have filtered me, but they all seem to know what my remarks are :-)
Anything new to say ?? No, i think that everything has already been said so nothing "new" in my book....
I will recap my posts for you....as your the only one "listening" :-)
It's not clear at all, what IMM will do with Lupuzor.....They might try it again on some other indication besides lupus, imo
For the moment they are trying to find a partner for Lupuzor in Lupus, there is a chance that they might find someone... but if not....what can they do ?
Although, Tim states that they have 2-3 years cash in the bank we all know that 10-12 million is not a huge amount when you're financing clinical trials, especially late stage trials so what are the options open to them ??
and
mo, The waiting game continues...
1) The results have been passed on and are being analysed by
- Possible future partners
- Imm regulatory advisers
This takes time....Weeks or more likely months before decisions are made...
IMM needs to be seen to move forward with the rest of the pipeline and to communicate on what'is left of the pipeline outside Lupuzor....until decisions have been taken on whether or not to file for approval
The speculation and the rumours will continue in the meantime, based on the movements on the SP...imv
so Andie....all old news....unless an Rns says different .....imo